Evidence map›Paper›PMID 32851784›Full record

ArticleInternational journal of laboratory hematology2020

Thrombosis and antiphospholipid antibodies in patients with SARS-COV-2 infection (COVID-19).

Xabier Gutiérrez López de Ocáriz, Nerea Castro Quismondo, Elena Vera Guerrero, Mario Rodríguez Rodríguez, Rosa Ayala Díaz, Joaquín Martínez López

Abstract readLetterComment
In one paragraph

Article in International journal of laboratory hematology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Effect of vitamin DClinics (Sao Paulo, Brazil) · 2024
    Trial
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. COVID-19 and antiphospholipid antibodies.Best practice & research. Clinical haematology · 2022
    Review
  15. COVID-19 coagulopathy and antiphospholipid syndrome.Revista colombiana de reumatologia · 2022
    Review
  16. Article
  17. Review
  18. Review
  19. COVID-19, Antiphospholipid Antibodies, and Catastrophic Antiphospholipid Syndrome: A Possible Association?Clinical medicine insights. Arthritis and musculoskeletal disorders · 2020
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Xabier Gutiérrez López de OcárizHospital Universitario 12 de Octubre, Madrid, España.ORCID 0000-0002-2622-5430
Nerea Castro QuismondoHospital Universitario 12 de Octubre, Madrid, España.
Elena Vera GuerreroHospital Universitario 12 de Octubre, Madrid, España.
Mario Rodríguez RodríguezHospital Universitario 12 de Octubre, Madrid, España.
Rosa Ayala DíazHospital Universitario 12 de Octubre, Madrid, España.
Joaquín Martínez LópezHospital Universitario 12 de Octubre, Madrid, España.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Coronavirus InfectionsPandemicsPneumonia, ViralThrombosisAntibodies, AntiphospholipidBetacoronavirusCOVID-19HumansSARS-CoV-2Antibodies, Antiphospholipid

Identifiers

PMID32851784
PMCPMC7461094

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.